Life Sciences 360

Welcome to episode 047 of Life Sciences 360.
In this video, We discuss the importance of using AI in decision making in the life sciences industry. Ben highlight the need for evidence-based decision making and the challenges of finding relevant information in a sea of data. Ben introduce InVision, a platform that helps biotech and pharma companies stay informed about clinical trials and changes in the industry.
Watch the video to learn how AI can assist in making informed decisions in the life sciences field.
Chapters :
00:00 - Introduction
00:24 - AI in Decision-Making
00:45 - Welcome and Guest Introduction
01:00 - InThought Research and Infernesis
02:00 - Challenges in Clinical Trials
03:40 - InVision Technology Platform
06:36 - AI Integration in InVision
08:22 - Machine Learning and Natural Language Processing
13:20 - Case Study: Clinical Trial Data Analysis
17:56 - Privacy and Regulation in Healthcare
19:34 - AI and Job Security
24:21 -Practical Applications of AI
26:16 - Spire Bioadvisors
29:40 - Trends in Biotech and Drug Development
32:58 - Future of AI in Healthcare
37:28 - Ben's Personal Insights
39:12 - Closing Thoughts
-----
Links:
* Ben Weintraub LinkedIn (https://www.linkedin.com/in/ben-weintraub-0566389/)
* inThought Research LinkedIn (https://www.linkedin.com/company/inthought-research/ )
* inThought Research website (https://inthought.com/)
*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/ )
*Listen to this episode on the go!
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr
👍 Like this video if you enjoy diving deep into the latest healthcare trends.
💬 Comment below any questions you have on Generative AI. Have you implemented this into your operations yet?
🔔 Subscribe to our channel @lifesciences360 for more expert interviews about the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.
#AIinHealthcare #ClinicalTrials #DrugDevelopment #LifeSciences360 #BiotechStartups #PersonalizedMedicine #GeneTherapy #MachineLearning #NaturalLanguageProcessing #HealthcareInnovation

For more, check out the podcast website - www.lifesciencespod.com

Welcome to episode 060 of Life Sciences 360.
In this episode of Life Sciences 360, host Harsh Thakkar sits down with Dr. Robin Odegaard, a high-performance business psychologist and professional confidant, to discuss the hidden struggles that come with success. They dive deep into topics like imposter syndrome, self-sabotage, complex priorities, and the loneliness that often accompanies high achievement. Dr. Robin shares actionable strategies and insights from her extensive work with lawyers, biotech CEOs, neurosurgeons, and more.
Chapters:
00:00 - Introduction
00:33 - The Voice in Your Head & Head Trash
01:29 - Dr. Robin’s Journey into High-Performance Psychology
02:48 - Understanding Self-Sabotage and How It Manifests
05:10 - The Loneliness of Success: Why It’s “Lonely at the Top”
07:23 - Techniques to Recognize and Combat Self-Sabotage
11:22 - Managing Complex Priorities with the “Foresting Project”
15:48 - Time Audits & Delegation for Effective Time Management
18:41 - The Challenge of Letting Go for High Performers
20:58 - Working with Diverse Clients: From Athletes to CEOs
23:03 - Emotional State Management for Better Communication
27:28 - The Isolation of Success & Who High Achievers Talk To
33:47 - Final Thoughts & Advice for Listeners
35:58 - Conclusion
Connect with Dr. Robin Odegaard:
- Website: (https://www.mentalmacgyver.com)
- LinkedIn: (https://www.linkedin.com/in/robinodegaard)
- YouTube: (https://www.youtube.com/@DrRobin)
Watch Next:
Take Out the Head Trash | How to Fight the Demons Keeping You Awake at 3 a.m
(https://youtu.be/Kx12TTCoojg?si=BDsG4KLZOVMO71HW)
Don’t forget to like, share, and subscribe for more insightful conversations on achieving success in life sciences and beyond!
---
Links:
*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/ )
*Listen to this episode on the go!
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr
👍 Like this video if you enjoy diving deep into the latest healthcare trends.
💬 Comment below any questions you have. Have you implemented this into your operations yet?
🔔 Subscribe to our channel @lifesciences360 for more expert interviews about the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.
Thank you for watching and supporting our channel!
#HighPerformance #ImposterSyndrome #SelfSabotage #MentalHealth #ExecutiveCoaching #Productivity #MindsetMatters #SuccessMindset #Leadership #PersonalDevelopment #Psychology #Loneliness #HeadTrash #Entrepreneurship #LifeSciences360

For more, check out the podcast website - www.lifesciencespod.com

In this episode of Life Sciences 360, we dive deep into the world of GLP-1 medications with Dr. Jonathan Kaplan. We discuss weight management, how these medications work, their impact beyond weight loss, and the ethical considerations surrounding their use. Dr. Kaplan shares his insights on the healthcare industry's evolving landscape, the economic implications, and why these medications are changing everything from cosmetic surgery to chronic disease management.
Chapters:
00:00 Introduction
00:02 Dr. Jonathan Kaplan’s Background
00:16 Overview of GLP-1 Medications
00:25 The Significance of GLP-1s
00:35 Future FDA Approvals
00:51 Welcome to the Episode
01:12 Meet Dr. Jonathan Kaplan
01:19 Dr. Kaplan’s Journey into Weight Management
02:09 Early Days Before the GLP-1 Hype
02:30 Compounding Pharmacy and Medication Shortages
03:17 Success of the Weight Management Program
03:23 YouTube Subscriber Request
04:17 GLP-1 Mechanisms Explained
05:00 How GLP-1s Work in the Body
05:51 Historical Timeline of GLP-1 Medications
06:48 Semaglutide’s Evolution
07:23 The Rise of Ozempic and Wegovy
07:43 New Developments in Weight Management
08:54 Accidental Discoveries and Hormones
09:35 Significance of GLP-1 Discoveries
10:02 Medication Approval and Insurance Hurdles
10:43 Patient Expectations vs. Reality
12:09 Misconceptions About Weight Loss
12:51 Other Health Benefits Beyond Weight Loss
14:10 The Complex Psychology of Weight Loss
15:16 Importance of Diet and Exercise
16:10 How to Get Access to These Medications
18:02 Transparent Pricing Model
20:19 Maintenance and Subscription Options
22:04 Challenges with Insurance
23:21 Insurance Pitfalls and Complications
24:42 Speed of Access and Medication Availability
25:41 Ethical Considerations in Prescribing GLP-1s
27:28 Balancing Ethics and Accessibility
29:35 Broader Impact on Public Health and Economics
30:35 Transforming Healthcare Through Weight Management
32:12 Future of GLP-1 Medications
33:58 Changing Consumer Preferences and Food Labels
35:51 Reflections on Dr. Kaplan’s Career
37:06 Closing Remarks
39:11 Key Takeaway on Safe Access
41:03 Conclusion and Gratitude
🔗 Links Mentioned:
Dr. Jonathan Kaplan, Founder and CEO at Build My Health
Linkedin - (https://www.linkedin.com/in/buildmybod/)
- Visit Dr. Jonathan Kaplan’s website: (https://www.drwell.com)
- Website : (https://www.buildmybod.com/author/kaplan/)
- Follow Dr. Well on TikTok and Instagram: (https://www.tiktok.com/@drwellrx)
- Contact Dr. Jonathan Kaplan: [email protected]
- Follow Life Sciences 360 on LinkedIn
(https://www.linkedin.com/company/life-sciences-360)
---
Subscribe to our podcast for more on life sciences:
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr
#GLP1 #WeightLoss #HealthCare #LifeSciences360 #DrJonathanKaplan #Ozempic #Wegovy #WeightManagement #HealthAndWellness #GLP1Medications #Type2Diabetes #ObesityTreatment #MedicalPodcast #HealthyLiving #Pharmaceuticals #Semaglutide #Medicine #SciencePodcast #MedicalResearch #PreventiveHealth

For more, check out the podcast website - www.lifesciencespod.com

Episode 005: Harsh Thakkar (@harshvthakkar) interviews Rohit Tyagi (@rohittyagi7), President of Sagax Team.
Rohit shares his transition from working in life sciences companies to building Sagax Team as a quality assurance and lab informatics consulting practice with 50+ consultants.
Rohit and Harsh discuss common mistakes life science companies make with software validation, managing changes and releases to SaaS systems, and leveraging vendor expertise to reduce cycle times for implementing laboratory and manufacturing systems.
Rohit wraps up the episode by sharing his thoughts on top traits to look for when hiring talent and the importance of training for employees.
-----
Links:

US FDA Computer Software Assurance (CSA) Guidance
* How Sagax Team can help with your IT projects
* Do you love LS 360 and want to see Harsh's smiling face? Subscribe to our YouTube channel.
------
Show Notes:
(2:18) - Common software validation mistakes

(9:22 ) - Rohit's take on CSA

(17:41) - Hiring people with no life sciences experience

(24:29) - Managing SaaS releases each year

(31:10) - Top traits to look for when hiring consultants

----

For more, check out the podcast website - www.lifesciencespod.com

In this episode of LifeSciences 360, we dive into the fascinating world of cell and gene therapy manufacturing with Carlos Yuraszeck. With over 16 years of experience, Carlos shares his deep insights into the unique challenges, opportunities, and innovations in the field, offering a detailed look into what it takes to bring life-saving therapies to patients. We cover everything from the design of manufacturing facilities to the complexities of quality systems, patient-centric innovations, and the future of allogeneic therapies.
If you're interested in the life sciences, cell and gene therapy, or just curious about cutting-edge advancements in medicine, this episode is for you!
Chapters:
00:00 - Intro
00:02 - Understanding Cell and Gene Therapy Facilities
00:09 - Challenges in Cell Therapy Facility Design
00:26 - Automation in Manufacturing
00:42 - Balancing Quality, Cost, and Time
00:53 - Patient-Centric Manufacturing
01:21 - Guest Introduction: Carlos Yuraszeck
02:06 - Carlos’s Journey in Cell and Gene Therapy
03:21 - Unique Factors in Facility Design
04:14 - Making Facilities Operational
05:09 - Subscription Appeal
06:13 - Autologous vs. Allogeneic Cell Therapies Explained
08:13 - Adjusting Processes Based on Patient Variability
09:37 - Stem Cell Derived Therapies
10:39 - Biotech Companies: Autologous or Allogeneic?
12:07 - Strategic Decisions in Facility Design
14:50 - Phase-Appropriate Quality Systems
16:45 - Regulatory Flexibility and Urgency for Patients
18:08 - Change Control in Early vs. Late Phases
19:02 - Batch Records and Operator Judgment
20:27 - Training Focus for Different Phases
22:38 - Balancing Regulatory Requirements and Innovation
24:32 - Risk Assessment Based on Patient Needs
26:18 - The Potential of CAR T Therapies
28:05 - The Allogeneic Space and Future Prospects
31:00 - The Transformative Impact of Cell Therapy
32:22 - Carlos’s Career Lessons and Fear of the Unknown
34:45 - Closing Remarks and Subscription Reminder
36:37 - Outro
---
🔗 Links Mentioned:
Connect with Carlos on LinkedIn:
https://www.linkedin.com/in/carlos-yuraszeck-5400091/
- Follow Life Sciences 360 on LinkedIn
(https://www.linkedin.com/company/life-sciences-360)
---
Subscribe to our podcast for more insights on life sciences:
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr
💬 Let us know in the comments: Did you know worms could be this powerful?
👍 Don't forget to hit Like and Subscribe for more fascinating interviews with leaders in life sciences!
Make sure to subscribe for more industry insights, and don't forget to leave a comment or question for our guest, Carlos Yuraszeck!
---
#Celltherapy #GMPoperations #executivedirector #astellaspharma #CellTherapyManufacturing #facilitydesign #DesigningCell

For more, check out the podcast website - www.lifesciencespod.com